| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HS31
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 27 | 31 | PF00656 | 0.641 |
| CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.459 |
| CLV_NRD_NRD_1 | 180 | 182 | PF00675 | 0.537 |
| CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.545 |
| CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.402 |
| CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.452 |
| CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.519 |
| CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.562 |
| CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.402 |
| CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.473 |
| CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.564 |
| CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.562 |
| CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.462 |
| CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.665 |
| CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.480 |
| CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.417 |
| CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.412 |
| DOC_MAPK_gen_1 | 11 | 20 | PF00069 | 0.472 |
| DOC_PP2B_LxvP_1 | 3 | 6 | PF13499 | 0.508 |
| DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.556 |
| DOC_USP7_UBL2_3 | 105 | 109 | PF12436 | 0.552 |
| DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.503 |
| DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.649 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.508 |
| LIG_BRCT_BRCA1_1 | 63 | 67 | PF00533 | 0.471 |
| LIG_FHA_1 | 80 | 86 | PF00498 | 0.476 |
| LIG_FHA_2 | 14 | 20 | PF00498 | 0.633 |
| LIG_FHA_2 | 92 | 98 | PF00498 | 0.511 |
| LIG_MAD2 | 163 | 171 | PF02301 | 0.553 |
| LIG_Pex14_2 | 174 | 178 | PF04695 | 0.561 |
| LIG_REV1ctd_RIR_1 | 172 | 181 | PF16727 | 0.555 |
| LIG_SH2_STAP1 | 37 | 41 | PF00017 | 0.431 |
| LIG_WRC_WIRS_1 | 80 | 85 | PF05994 | 0.444 |
| MOD_CDK_SPK_2 | 123 | 128 | PF00069 | 0.645 |
| MOD_CK2_1 | 13 | 19 | PF00069 | 0.586 |
| MOD_CK2_1 | 91 | 97 | PF00069 | 0.509 |
| MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.663 |
| MOD_GSK3_1 | 22 | 29 | PF00069 | 0.638 |
| MOD_NEK2_1 | 35 | 40 | PF00069 | 0.497 |
| MOD_NEK2_1 | 50 | 55 | PF00069 | 0.629 |
| MOD_PKA_1 | 91 | 97 | PF00069 | 0.535 |
| MOD_PKA_2 | 91 | 97 | PF00069 | 0.475 |
| MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.646 |
| TRG_ER_diArg_1 | 90 | 92 | PF00400 | 0.423 |
| TRG_NLS_Bipartite_1 | 91 | 109 | PF00514 | 0.537 |
| TRG_NLS_MonoCore_2 | 104 | 109 | PF00514 | 0.471 |
| TRG_NLS_MonoCore_2 | 178 | 183 | PF00514 | 0.567 |
| TRG_NLS_MonoExtC_3 | 104 | 109 | PF00514 | 0.567 |
| TRG_NLS_MonoExtC_3 | 178 | 184 | PF00514 | 0.565 |
| TRG_NLS_MonoExtN_4 | 177 | 183 | PF00514 | 0.511 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PC96 | Leptomonas seymouri | 79% | 99% |
| A0A0S4J1V1 | Bodo saltans | 52% | 98% |
| A0A1X0NLC2 | Trypanosomatidae | 64% | 100% |
| A0A3R7MRB1 | Trypanosoma rangeli | 58% | 88% |
| A0A3S7WNN7 | Leishmania donovani | 99% | 100% |
| C9ZY23 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
| E9AK18 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| Q9XZX5 | Leishmania major | 97% | 100% |